 |
 |

Association of C-Reactive Protein With Cognitive Impairment
James M. Noble, MD, MS;
Jennifer J. Manly, PhD;
Nicole Schupf, PhD;
Ming Xing Tang, PhD;
Richard Mayeux, MD, MS;
José A. Luchsinger, MD, MPH
Arch Neurol. 2010;67(1):87-92.
Background High-sensitivity C-reactive protein (hsCRP) is a biomarker of cardiovascular risk that is suggested to be a biomarker for cognitive impairment.
Objective To explore the association between hsCRP and cognitive impairment.
Design Cross-sectional analysis of a population-based community aging study.
Setting Northern Manhattan, New York, New York.
Other Participants One thousand three hundred thirty-one participants from a longitudinal study of aging without dementia and with available hsCRP and neuropsychological testing data at baseline.
Main Outcome Measures Four cognitive scores (memory, visuospatial, executive, and language impairment) derived from a neuropsychological battery. Cognitive impairment was defined by scores below 1.5 SDs of demographically corrected means.
Results Participants in the highest hsCRP tertile had higher adjusted odds of impaired memory (odds ratio [OR], 1.5; 95% confidence interval [CI], 1.0-2.1; P = .03) than participants in the lowest tertile. Subjects in the highest hsCRP tertile also had greater odds of visuospatial impairment (OR, 1.6; 95% CI, 1.0-2.3; P = .03). Higher hsCRP was not associated with executive or language impairment. Persons with at least 1 APOE 4 allele and hsCRP in the highest tertile had the greatest odds of impaired memory (OR, 2.7; 95% CI, 1.6-4.4).
Conclusions High hsCRP may be a marker of memory and visuospatial impairment in the elderly. The role of APOE 4 requires further exploration.
Author Affiliations: Gertrude H. Sergievsky Center, Columbia University (Drs Noble, Manly, Schupf, Tang, Mayeux, and Luchsinger); Taub Institute for Research of Alzheimer's Disease and the Aging Brain, Columbia University (Drs Noble, Manly, Schupf, Mayeux, and Luchsinger); Departments of Neurology (Drs Noble and Mayeux) and Psychiatry (Dr Mayeux), and Division of General Medicine, Department of Medicine (Dr Luchsinger), Columbia University College of Physicians and Surgeons; and Departments of Epidemiology (Drs Schupf, Mayeux, and Luchsinger) and Biostatistics (Dr Tang), Joseph P. Mailman School of Public Health, Columbia University, New York, New York.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
RELATED ARTICLE
This Month in Archives of Neurology
Arch Neurol. 2010;67(1):13-14.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease: Results From the Framingham Heart Study
van Himbergen et al.
Arch Neurol 2012;0:archneurol.2011.670v1-7.
ABSTRACT
| FULL TEXT
Cognitive dysfunction with aging and the role of inflammation
Simen et al.
Therapeutic Advances in Chronic Disease 2011;2:175-195.
ABSTRACT
|